Subacute necrotizing encephalomyelopathy. Clinical, ultrastructural, biochemical and therapeutic studies in an infant.
Subacute necrotizing encephalomyelopathy (SNE) has been observed in an infant with regressing psychomotor development. The concentrations of alanine, pyruvate and lactate were increased in the serum and blood as well as in the cerebrospinal fluid. Pyruvate carboxylase activity was reduced in the liver tissue. An inhibitor of thiamine-pyrophosphate-ATP-phosphotransferase was present in the urine. Thiamine treatment was followed by a decrease of serum alanine and blood pyruvate and lactate, but there was no clinical improvement during a period of 17 months. Ultrastructural investigations revealed high glycogen levels in liver tissue and skeletal muscle. These findings contrast with decreased gluconeogenesis, which is suggested by the diminished pyruvate carboxylase activity. Therefore it is concluded that reduced hepatic pyruvate carboxylase activity is not the primary cause of SNE.
D000409:Alanine / Q000097:blood / Q000134:cerebrospinal fluid; D001933:Brain Stem / Q000473:pathology; D004678:Encephalomalacia / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D005260:Female; D006003:Glycogen / Q000378:metabolism; D006801:Humans; D007223:Infant; D008607:Intellectual Disability / Q000188:drug therapy / Q000378:metabolism; D007773:Lactates / Q000097:blood / Q000134:cerebrospinal fluid; D008099:Liver / Q000201:enzymology / Q000648:ultrastructure; D008112:Liver Glycogen / Q000378:metabolism; D009132:Muscles / Q000648:ultrastructure; D011596:Psychomotor Disorders / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D011766:Pyruvate Carboxylase / Q000378:metabolism; D011773:Pyruvates / Q000097:blood / Q000134:cerebrospinal fluid; D013577:Syndrome; D013831:Thiamine / Q000627:therapeutic use
D007773:Lactates; D008112:Liver Glycogen; D011773:Pyruvates; D006003:Glycogen; D011766:Pyruvate Carboxylase; D000409:Alanine; D013831:Thiamine